Novo Nordisk is facing “unprecedented” price pressures, “intensifying competition” and patents expiring.
Source: https://www.bbc.com/news/articles/c8e5zzrjllgo?at_medium=RSS&at_campaign=rss
About the Author
stocks news and daily news
